EXPLORE!

Medical Voice 8th December 2020

  882 Views

Dr KK Aggarwal    08 December 2020

Covid can cause permanent damage to lungs, says study

MEERUT: A research by Northwestern Memorial Hospital, Chicago, has found that Covid-19 in some patients can lead to irreversible and permanent lung damage, rendering them irrecoverable, and leaving lung transplantation as the only option for survival. Meerut-born Dr Ankit Bharat, chief of thoracic surgery and surgical director of the lung transplant program at the hospital in Chicago, had also conducted the first lung transplant on a Covid-19 patient in the US in June 2020. Dr. Bharat, who is also the principal investigator of the study published in peer-reviewed Science Translational Medicine journal of the Science Magazine, said organ transplantation may become more frequent for victims of the most severe forms of Covid-19. “We provided explicit evidence that Covid-19 can cause permanent damage to lungs in some patients for whom lung transplantation is the only hope for survival,” Dr Bharat told TOI. ....read more

Toothfall and Other Dental Issues in COVID-19

Sore jaws, cracked teeth are COVID collateral damage? Join us today at 7:00 PM on MEDtalks with Dr K K Aggarwal as he discusses gum disease associated to COVID-19 and other tooth related issues.Just click on www.facebook.com/drkkaggarwal or https://perfecthealthmela.com/vevent2/hall1a.php

CMAAO Coronavirus Facts and Myth Buster: Direct oral anticoagulant use

With input from Dr Monica Vasudev1186: Direct oral anticoagulant use not tied to reduced risk of severe COVID-19 DG Alerts Excerpts:Prognosis would not be altered by early outpatient DOAC initiation as per a study in Journal of Internal Medicine. Identified as a prominent feature of severe COVID-19, managing hypercoagulability in hospitalized patients has largely been focused, with interim guidelines supporting anticoagulation, suggest researchers led by Benjamin Flam, MD, Karolinska University Hospital, Stockholm, Sweden. Pre-emptive anticoagulation before or at the time of severe acute respiratory syndrome coronavirus 2 (SARS-CoV-2) infection to protect against severe disease is theoretically appealing; however, there is a lack of real-world data. Only small studies of COVID-19 patient cohorts have been conducted which have shown mixed results. ....read more

CMAAO Coronavirus Facts and Myth Buster: Shedding of viable SARS-CoV-2 following immunosuppressive therapy for cancer

DG Alerts Excerpts: Patients with COVID-19 and with immunosuppression after undergoing hematopoietic stem-cell transplantation or receiving cellular therapies may shed viable SARS-CoV-2 for at least 2 months, suggests a study published in The New England Journal of Medicine. Teresa Aydillo, Icahn School of Medicine at Mount Sinai, New York, and colleagues employed cell cultures to identify viable virus in serially collected nasopharyngeal and sputum samples that were obtained from 20 immunocompromised patients diagnosed with COVID-19 from March 10 through April 20, 2020. The median age of the cohort was 51 years and 55% were males. The most prevalent underlying diseases included lymphoma (40%) and multiple myeloma (35%), while 20% and 5% of patients had acute leukemia/myelodysplastic syndrome and chronic leukemia, respectively. Eleven patients developed severe COVID-19. ....read more

Understanding exact speech

Upanishads, Yoga sutras of Patanjali and teachings of Gautam Buddha, all talk about "the right speech". As per Gautam Buddha, the right speech has three components:  ●It should be based on truthfulness.  ●It should be necessary.  ●It should be kind. ....read more

Video of The day

understanding 2nd to 4th week after COVID 19

Healthcare News Monitor

Pfizer Versus Oxford Vaccine: How Much Will it Cost in India?

india.com

Coronavirus Vaccine Update: Two breakthrough firms in the race for coronavirus vaccine – Pfizer and Serum Institute (Oxford-AztraZeneca) – have sought for the emergency use authorisation of their vaccine candidate in India to fast forward the process of immunization against the deadly viral disease. While both Pfizer and Oxford vaccines have shown promising results in phase 3 clinical trials, one of them is likely to cost more than the other. Also Read - Great Honour: Cambridge University Names its Chemistry Department After Indian Scientist Yusuf Hamied

Coronavirus: How Indian airports are preparing for distribution of chilled vaccines

oneindia.com

New Delhi, Dec 07: As some of the coronavirus vaccine trials across the world are in their final stages, the central government has started preparations to handle the distribution of vaccines in the country at ultra-low temperatures. While no COVID-19 vaccine has yet been approved, the vaccines developed by Pfizer and BioNTech is the most advanced in the process and could be ready for rapid production and distribution next month.

Unpaid for six months, physically disabled doctor writes to Delhi L-G

newindianexpress.com

NEW DELHI: Unpaid for six months, a frontline healthcare worker in the city associated with the North Delhi Municipal Corporation (NDMC) has written to Lieutenant-Governor Anil Baijal over the issue. Dr Sumit Anand, posted at the Urban Health Centre, WEA, Karol Bagh, has been working for the past four years has not been paid since June. In his letter, he also claimed that the civic body has been pressurising him to sign faulty salary paybills without increment.

Doctor In Haryana Runs A Free Clinic And Organises Community Kitchen For The Underprivileged

indiatimes.com

Dr. Rajesh Mehta lost his elder brother in a road accident 31 years ago. His loss drove him to do more to help those in need, so now he goes to several hospitals in Hisar, Haryana, and runs a free clinic for homeopathic medicine for the needy, as per a report in The New Indian Express. Once a week, with other members of his family, the doctor organises a community kitchen for kids, and also provides them with stationary. “In 1989 my elder brother, who was my inspiration, died in an accident. Deep sorrow gradually led me to believe that it was time for me to give something back to society, after all, we always work for our own selves,” he said.

To comment on this article,
create a free account.

Sign Up to instantly get access to 10000+ Articles & 1000+ Cases

Already registered?

Login Now

Most Popular Articles

News and Updates

eMediNexus provides latest updates on medical news, medical case studies from India. In-depth medical case studies and research designed for doctors and healthcare professionals.